AAPL339.75+0.77 (+0.23%) ▲|ABBV265.21+0.73 (+0.28%) ▲|ABT103.69+0.71 (+0.69%) ▲|ACN183.72-2.39 (-1.28%) ▼|ADBE238.25-11.27 (-4.52%) ▼|AMAT472.46+8.22 (+1.77%) ▲|AMD623.77+8.25 (+1.34%) ▲|AMGN410.24+17.08 (+4.34%) ▲|AMT175.25+0.65 (+0.37%) ▲|AMZN254.98-3.47 (-1.34%) ▼|AVGO364.54+1.88 (+0.52%) ▲|AXP305.07-8.52 (-2.72%) ▼|BA197.72-3.43 (-1.71%) ▼|BAC56.20-1.76 (-3.04%) ▼|BKNG164.22-4.30 (-2.55%) ▼|BLK1,066.66-23.61 (-2.17%) ▼|BMY62.25-0.37 (-0.59%) ▼|BNY150.17-3.72 (-2.42%) ▼|BRK-B503.49+1.48 (+0.29%) ▲|C132.47-2.58 (-1.91%) ▼|CAT808.01-8.49 (-1.04%) ▼|CL87.05+0.79 (+0.92%) ▲|CMCSA22.42-0.51 (-2.22%) ▼|COF200.55-4.37 (-2.13%) ▼|COP125.27-2.26 (-1.77%) ▼|COST899.41+0.93 (+0.10%) ▲|CRM233.28-3.14 (-1.33%) ▼|CSCO106.44-5.02 (-4.50%) ▼|CVS87.10-0.50 (-0.57%) ▼|CVX202.41-1.26 (-0.62%) ▼|DE703.12+18.39 (+2.69%) ▲|DHR221.09+5.25 (+2.43%) ▲|DIS103.82-0.41 (-0.39%) ▼|DUK116.31-0.43 (-0.37%) ▼|EMR154.19+2.47 (+1.63%) ▲|FDX295.94+0.15 (+0.05%) ▲|GD343.39-10.51 (-2.97%) ▼|GE319.22+0.21 (+0.07%) ▲|GEV950.28+4.06 (+0.43%) ▲|GILD152.67+2.11 (+1.40%) ▲|GM83.45-0.50 (-0.60%) ▼|GOOG347.41-3.46 (-0.99%) ▼|GOOGL351.16-3.81 (-1.07%) ▼|GS949.49-9.90 (-1.03%) ▼|HD305.35+8.15 (+2.74%) ▲|HON211.85+5.37 (+2.60%) ▲|IBM231.38-0.55 (-0.24%) ▼|INTC123.86+2.08 (+1.71%) ▲|INTU292.35-11.77 (-3.87%) ▼|ISRG402.09+0.44 (+0.11%) ▲|JNJ269.19-0.28 (-0.10%) ▼|JPM340.00-12.04 (-3.42%) ▼|KO88.61+1.49 (+1.71%) ▲|LIN464.91+7.41 (+1.62%) ▲|LLY1,170.14+5.25 (+0.45%) ▲|LMT522.34-13.06 (-2.44%) ▼|LOW196.08+5.10 (+2.67%) ▲|LRCX310.96+8.68 (+2.87%) ▲|MA555.89-11.76 (-2.07%) ▼|MCD250.35+2.47 (+1.00%) ▲|MDLZ61.08+0.91 (+1.51%) ▲|MDT90.77-0.98 (-1.07%) ▼|META736.60-4.65 (-0.63%) ▼|MMM169.30+4.33 (+2.62%) ▲|MO68.64+0.11 (+0.16%) ▲|MRK150.91+1.41 (+0.94%) ▲|MS200.18-5.94 (-2.88%) ▼|MSFT498.00-3.61 (-0.72%) ▼|MU1,096.16+52.20 (+5.00%) ▲|NEE79.26-0.37 (-0.46%) ▼|NFLX72.16-1.20 (-1.64%) ▼|NKE36.10+0.00 (+0.00%) ▲|NOW137.00-0.68 (-0.49%) ▼|NVDA228.87+1.49 (+0.66%) ▲|ORCL149.20+0.64 (+0.43%) ▲|PEP131.19+1.60 (+1.23%) ▲|PFE27.93+0.19 (+0.68%) ▲|PG148.22+2.14 (+1.47%) ▲|PLTR184.99+1.92 (+1.05%) ▲|PM190.23+2.75 (+1.47%) ▲|QCOM198.27+4.04 (+2.08%) ▲|RTX190.99-3.35 (-1.72%) ▼|SBUX95.11+0.21 (+0.22%) ▲|SCHW100.35-6.53 (-6.11%) ▼|SO85.15-0.31 (-0.36%) ▼|SPG205.95+0.97 (+0.47%) ▲|T25.10-0.35 (-1.38%) ▼|TMO658.52-0.24 (-0.04%) ▼|TMUS162.41-2.86 (-1.73%) ▼|TSLA378.90+3.69 (+0.98%) ▲|TXN271.41+0.54 (+0.20%) ▲|UBER69.89-0.95 (-1.34%) ▼|UNH372.95-4.61 (-1.22%) ▼|UNP274.41+4.78 (+1.77%) ▲|UPS95.87+1.12 (+1.18%) ▲|USB59.44-1.00 (-1.65%) ▼|V362.04-7.91 (-2.14%) ▼|VZ46.45-1.23 (-2.58%) ▼|WFC83.15-3.39 (-3.92%) ▼|WMT110.12+2.68 (+2.49%) ▲|XOM158.71+0.41 (+0.26%) ▲|AAPL339.75+0.77 (+0.23%) ▲|ABBV265.21+0.73 (+0.28%) ▲|ABT103.69+0.71 (+0.69%) ▲|ACN183.72-2.39 (-1.28%) ▼|ADBE238.25-11.27 (-4.52%) ▼|AMAT472.46+8.22 (+1.77%) ▲|AMD623.77+8.25 (+1.34%) ▲|AMGN410.24+17.08 (+4.34%) ▲|AMT175.25+0.65 (+0.37%) ▲|AMZN254.98-3.47 (-1.34%) ▼|AVGO364.54+1.88 (+0.52%) ▲|AXP305.07-8.52 (-2.72%) ▼|BA197.72-3.43 (-1.71%) ▼|BAC56.20-1.76 (-3.04%) ▼|BKNG164.22-4.30 (-2.55%) ▼|BLK1,066.66-23.61 (-2.17%) ▼|BMY62.25-0.37 (-0.59%) ▼|BNY150.17-3.72 (-2.42%) ▼|BRK-B503.49+1.48 (+0.29%) ▲|C132.47-2.58 (-1.91%) ▼|CAT808.01-8.49 (-1.04%) ▼|CL87.05+0.79 (+0.92%) ▲|CMCSA22.42-0.51 (-2.22%) ▼|COF200.55-4.37 (-2.13%) ▼|COP125.27-2.26 (-1.77%) ▼|COST899.41+0.93 (+0.10%) ▲|CRM233.28-3.14 (-1.33%) ▼|CSCO106.44-5.02 (-4.50%) ▼|CVS87.10-0.50 (-0.57%) ▼|CVX202.41-1.26 (-0.62%) ▼|DE703.12+18.39 (+2.69%) ▲|DHR221.09+5.25 (+2.43%) ▲|DIS103.82-0.41 (-0.39%) ▼|DUK116.31-0.43 (-0.37%) ▼|EMR154.19+2.47 (+1.63%) ▲|FDX295.94+0.15 (+0.05%) ▲|GD343.39-10.51 (-2.97%) ▼|GE319.22+0.21 (+0.07%) ▲|GEV950.28+4.06 (+0.43%) ▲|GILD152.67+2.11 (+1.40%) ▲|GM83.45-0.50 (-0.60%) ▼|GOOG347.41-3.46 (-0.99%) ▼|GOOGL351.16-3.81 (-1.07%) ▼|GS949.49-9.90 (-1.03%) ▼|HD305.35+8.15 (+2.74%) ▲|HON211.85+5.37 (+2.60%) ▲|IBM231.38-0.55 (-0.24%) ▼|INTC123.86+2.08 (+1.71%) ▲|INTU292.35-11.77 (-3.87%) ▼|ISRG402.09+0.44 (+0.11%) ▲|JNJ269.19-0.28 (-0.10%) ▼|JPM340.00-12.04 (-3.42%) ▼|KO88.61+1.49 (+1.71%) ▲|LIN464.91+7.41 (+1.62%) ▲|LLY1,170.14+5.25 (+0.45%) ▲|LMT522.34-13.06 (-2.44%) ▼|LOW196.08+5.10 (+2.67%) ▲|LRCX310.96+8.68 (+2.87%) ▲|MA555.89-11.76 (-2.07%) ▼|MCD250.35+2.47 (+1.00%) ▲|MDLZ61.08+0.91 (+1.51%) ▲|MDT90.77-0.98 (-1.07%) ▼|META736.60-4.65 (-0.63%) ▼|MMM169.30+4.33 (+2.62%) ▲|MO68.64+0.11 (+0.16%) ▲|MRK150.91+1.41 (+0.94%) ▲|MS200.18-5.94 (-2.88%) ▼|MSFT498.00-3.61 (-0.72%) ▼|MU1,096.16+52.20 (+5.00%) ▲|NEE79.26-0.37 (-0.46%) ▼|NFLX72.16-1.20 (-1.64%) ▼|NKE36.10+0.00 (+0.00%) ▲|NOW137.00-0.68 (-0.49%) ▼|NVDA228.87+1.49 (+0.66%) ▲|ORCL149.20+0.64 (+0.43%) ▲|PEP131.19+1.60 (+1.23%) ▲|PFE27.93+0.19 (+0.68%) ▲|PG148.22+2.14 (+1.47%) ▲|PLTR184.99+1.92 (+1.05%) ▲|PM190.23+2.75 (+1.47%) ▲|QCOM198.27+4.04 (+2.08%) ▲|RTX190.99-3.35 (-1.72%) ▼|SBUX95.11+0.21 (+0.22%) ▲|SCHW100.35-6.53 (-6.11%) ▼|SO85.15-0.31 (-0.36%) ▼|SPG205.95+0.97 (+0.47%) ▲|T25.10-0.35 (-1.38%) ▼|TMO658.52-0.24 (-0.04%) ▼|TMUS162.41-2.86 (-1.73%) ▼|TSLA378.90+3.69 (+0.98%) ▲|TXN271.41+0.54 (+0.20%) ▲|UBER69.89-0.95 (-1.34%) ▼|UNH372.95-4.61 (-1.22%) ▼|UNP274.41+4.78 (+1.77%) ▲|UPS95.87+1.12 (+1.18%) ▲|USB59.44-1.00 (-1.65%) ▼|V362.04-7.91 (-2.14%) ▼|VZ46.45-1.23 (-2.58%) ▼|WFC83.15-3.39 (-3.92%) ▼|WMT110.12+2.68 (+2.49%) ▲|XOM158.71+0.41 (+0.26%) ▲|
18.2 C
New York
Wednesday, September 23, 2026

Tag: program

NurExone Advances U.S. Growth Strategy with Acceptance into Prestigious ARMI HealthTech Hub Accelerator and Provides Corporate Update

TORONTO and HAIFA, Israel, June 20, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“NurExone” or the “Company”), a biotech company developing exosome-based therapies for central nervous system injuries, announced today that it has been accepted into the HealthTech Hub (“HTH”) Accelerator Program. Based in Boston, Massachusetts, home to more than 1,000 biotech companies1, HTH is operated by the Advanced Regenerative Manufacturing Institute (“ARMI”) and its BioFabUSA initiative.

Dupixent® (dupilumab) Approved in the U.S. as the Only Targeted Medicine to Treat Patients with Bullous Pemphigoid (BP)

Approval based on pivotal results showing improvements in sustained disease remission and reductions in itch and oral corticosteroid use compared to placebo in adults with BP

Press Release: Dupixent approved in the US as the only targeted medicine to treat patients with bullous pemphigoid

Dupixent approved in the US as the only targeted medicine to treat patients with bullous pemphigoid

OMS Energy Technologies Inc. Mengeluarkan Kemas Kini Operasi Pasca-IPO yang Menampilkan Pertumbuhan Pelanggan, Inisiatif Pengembangan, serta Pencapaian R&D dan Keselamatan

SINGAPURA, June 20, 2025 (GLOBE NEWSWIRE) -- OMS Energy Technologies Inc. (“OMS” atau “Syarikat”) (Nasdaq: OMSE), sebuah pengeluar yang berorientasikan pertumbuhan bagi sistem kepala telaga permukaan (“SWS”) dan barangan tubular untuk industri minyak dan gas (“OCTG”), hari ini mengeluarkan kemas kini perniagaan yang menggariskan pencapaian terkini sambil Syarikat bersiap sedia untuk panggilan pendapatan sulungnya selepas berjaya disenaraikan di Nasdaq pada Mei 2025.

HealthRX Expands Telehealth Website Experience to Include GLP-1 Weight Loss Solutions, Prescription Access, and 24/7 Wellness Support

HealthRX enhances online platform to offer doctor-prescribed GLP-1 medications like Ozempic® and Zepbound® for adults seeking virtual weight loss support, prescription access, and 24/7 telehealth care
HealthRX enhances online platform to offer doctor-prescribed GLP-1 medications like Ozempic® and Zepbound® for adults seeking virtual weight loss support, prescription access, and 24/7 telehealth care

National Bank of Canada Announces NVCC Subordinated Notes Offering

/NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES./ MONTREAL, June 19, 2025 /CNW/ - National Bank of Canada...

HomeSafe Alliance Announces TRANSCOM’s Notice to Terminate Global Household Goods Contract

HOUSTON, June 19, 2025 /PRNewswire/ -- HomeSafe Alliance received on June 18, 2025, a notice from the U.S. Department of Defense's Transportation Command (TRANSCOM)...

HER2-low Cancers Market Set to Register Immense Growth at a CAGR of 9.4% During the Study Period (2020-2034) | DelveInsight

The future of the HER2-low cancer treatment market is poised for significant transformation, driven by the approval of ENHERTU and the advancement of other...

Costa Rica Strengthens Its Position as a Regional Hub for the Audiovisual Industry with New Regional Market

Costa Rica Media Market will take place June 24–25 in San José, with over 500 business meetings and participation from buyers, producers, and experts...

Premier Health Announces a Strategic Review Process to Enhance Shareholder Value

MONTRÉAL, June 19, 2025 (GLOBE NEWSWIRE) -- Premier Health of America Inc. (TSXV: PHA) (the “Company” or “Premier Health”), a leading Canadian health tech company, today announced that its Board of Directors (the “Board”) has initiated a formal strategic review process to identify, review and evaluate a broad range of potential strategic alternatives available to it with a view to continuing to enhance shareholder value.

PECO Pallet Wins CITT Award for Environmental Sustainability

CITT awards PECO its inaugural SME Sustainability Award for environmental leadership. ITASCA, Ill., June 19, 2025 /PRNewswire/ -- PECO Pallet announced today that it...

Biological Safety Cabinets Market to Reach USD 448.4 Million by 2032, Driven by Rising Biosafety Standards and Research Demand

PUNE, India, June 19, 2025 /PRNewswire/ -- According to a recent market analysis published by Credence Research Inc., the global Biological Safety Cabinets (BSCs) market...

Hard Rock Bet Launches Legendary Reward Drops

New rewards program to complement more streamlined loyalty integration into Unity by Hard Rock for unmatched omnichannel benefits HOLLYWOOD, Fla., June 19, 2025 /PRNewswire/ -- Hard...

Michigan Meijer Customers Saved Nearly $200 Million Through mPerks During the Last Year

GRAND RAPIDS, Mich., June 19, 2025 /PRNewswire/ -- Midwest retailer Meijer announced today that Michigan customers saved nearly $200 million in the past year...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsProgram